VectorY is pioneering vectorized antibody therapies to reverse the course of neurodegenerative disease, with a strong pipeline of potentially disease-modifying treatments for ALS, Huntington’s, and Parkinson’s disease
VectorY is pioneering vectorized antibody therapies to reverse the course of neurodegenerative disease, with a strong pipeline of potentially disease-modifying treatments for ALS, Huntington’s, and Parkinson’s disease.